UPDATE: Mizuho Securities Upgrades Sabra Healthcare REIT Inc. (SBRA) to Buy

Mizuho Securities analyst Vikram Malhotra upgraded Sabra Healthcare REIT Inc. (NASDAQ: SBRA) from Neutral to Buy with a price target of $15.00 (from $16.00).

The analyst comments "After being vocally negative on Skilled Nursing during the past six months, we upgrade Sabra to Buy with a $15 price target, implying over 12% upside. While there remains debate on this sub-sector, we now see this as a tactically opportune time to upgrade, given a) several negatives are well-known, b) we see occupancy slowly but steadily improving, with a low bar amongst the investor community, c) a high probability the public health emergency (and associated benefits) gets extended, and d) our sensitivity analysis suggests the dividend (9% yield) is covered in our base and bull cases. Our price target assumes a modest expansion in AFFO multiples from the current 10x."

For an analyst ratings summary and ratings history on Sabra Healthcare REIT Inc. click here. For more ratings news on Sabra Healthcare REIT Inc. click here.

Shares of Sabra Healthcare REIT Inc. closed at $13.37 yesterday.

You May Also Be Interested In

• UPDATE: UBS Upgrades Henry Schein (HSIC) to Neutral
• UPDATE: JPMorgan Downgrades Nektar Therapeutics (NKTR) to Underweight
• UPDATE: Roth Capital Upgrades Centrus Energy Corp. (LEU) to Buy